|Issue 1165: February 3, 2015
IAC WEB SECTIONS
JOURNAL ARTICLES AND NEWSLETTERS
2015 U.S. recommended immunization schedule for adults now available
On February 3, CDC published online the Recommended Immunization Schedules for Adults, United States, 2015.
Each year, the Advisory Committee on Immunization Practices (ACIP) updates the immunization schedules to reflect current recommendations for licensed vaccines. In October 2014, ACIP approved the recommended immunization schedules for 2015. The 2015 recommended immunization schedules are effective January 1, 2015; the MMWR notice about the schedules’ publication date will be published February 6, 2015.
The recommended adult immunization schedule has been approved by the ACIP, the American Academy of Family Physicians, the American College of Physicians, the American College of Obstetricians, the American College of Gynecologists, and the American College of Nurse-Midwives.
CDC updates the press on multi-state measles outbreak as number of cases increases
On January 29, CDC held a telebriefing for the press about the multi-state measles outbreak that started in California in December 2014. An excerpt from an introductory statement made by Anne Schuchat, MD, assistant surgeon general, United States Public Health Service, and director of CDC’s National Center for Immunization and Respiratory Diseases, is reprinted below.
Thank you so much for joining us this afternoon. I want to talk to you today about measles and here's why. It's only January and we have already had a very large number of measles cases. As many cases as we typically have all year in typical years. This worries me and I want to do everything possible to prevent measles from getting a foothold in the United States and becoming endemic again. I want to make sure that parents who think that measles is gone and haven't made sure that they or their children are vaccinated are aware that measles is still around and it can be serious. And that MMR vaccine is safe and effective and highly recommended. From January 1 until January 28, 2015, a total of 84 people in 14 states have been reported as having measles. Most of these cases are part of an ongoing large multi-state outbreak linked to the Disneyland theme parks in California. CDC is working with state and local health departments to control this outbreak, which started in late December.…
Many resources available to help educate healthcare professionals and the public about measles
In light of the ongoing measles outbreak that started in California in 2014, and has spread to 14 states and Mexico, CDC has highlighted a number of resources to help healthcare providers recognize and diagnose measles. In addition, a number of resources from various sources are available to educate parents.
For healthcare professionals
CDC provides healthcare providers with new resources about using antivirals to treat patients with influenza
CDC has reported widespread influenza activity in most U.S. states, with influenza A (H3N2) viruses most common. H3N2-predominant influenza seasons have been associated with increased hospitalizations and deaths in older people and young children. Hospitalization rates are especially high among people 65 years and older. Antiviral medications are effective in treating influenza and reducing complications, and are available and recommended, but evidence suggests that they are underutilized. The following are some resources developed by CDC to help healthcare professionals properly use antiviral treatment when appropriate:
Reminder: CDC requests nominations for its Childhood Immunization Champion Awards for every state
The CDC Childhood Immunization Champion Award is an annual award that recognizes individuals who make a significant contribution toward improving public health through their work involving childhood immunization in their state.
Each year, up to one CDC Immunization Champion from each of the 50 U.S. states, eight U.S. territories and freely associated states, and the District of Columbia will be honored. Champions can include coalition members, parents, healthcare professionals (e.g., physicians, nurses, physicians’ assistants, nurse practitioners, medical assistants), and other immunization leaders who meet the award criteria. Immunization program managers, state and federal government employees paid by state or federal immunization funding, individuals who have been affiliated with and/or employed by pharmaceutical companies, and those who have already received the award are not eligible to apply (for details, see page 3 of the nomination packet).
Awardees will be announced during National Infant Immunization Week (NIIW), which runs April 18–25 this year. Champions will receive a certificate of recognition, will be featured on CDC’s web site, and may be recognized by their immunization program during NIIW.
All nomination forms are due to respective immunization programs. The suggested due date is February 6, 2015, but states may select a different deadline. Please contact your state immunization program to confirm your state’s deadline.
Registration for the May National Adult and Influenza Immunization Summit invitation-only meeting now open
The 2015 National Adult and Influenza Immunization Summit (NAIIS) will take place on May 12–14, in Atlanta, Georgia. A preliminary agenda and registration information are available on the Summit website. Note: The password needed for registration to this invitation-only meeting has been shared directly with Summit members. If you are not a Summit member and are interested in more information about becoming a member or attending this meeting, please email Dr. Litjen Tan at firstname.lastname@example.org.
IAC Spotlight! Hundreds of images/photos about vaccination and vaccine-preventable diseases are available for your use
When it comes to educating the public and healthcare professionals about the serious health effects of vaccine-preventable diseases, nothing else packs the punch of a visual image. The IAC Image Library on immunize.org provides access to hundreds of disease and vaccination-related images.
IAC has brought together images of people suffering from vaccine-preventable diseases; pictures of healthcare professionals vaccinating children, teens, and adults; and photos taken during various global immunization campaigns, as well as pathology specimens and micrographs of viruses and bacteria. Almost all of the images are free to download and can be used in lectures, articles, and presentations.
IAC enrolls eight more birthing institutions into its Hepatitis B Birth Dose Honor Roll; four previously honored institutions qualify for a second year
The Immunization Action Coalition (IAC) is pleased to announce that eight new institutions have been accepted into its Hepatitis B Birth Dose Honor Roll. The birthing institutions are listed below with their reported hepatitis B birth dose coverage rates in parentheses.
The Honor Roll is a key part of IAC’s major initiative urging the nation’s hospitals to Give birth to the end of Hep B. Hospitals and birthing centers are recognized for attaining high coverage rates for administering hepatitis B vaccine at birth and meeting specific additional criteria. The initiative urges qualifying healthcare organizations to apply for the Hepatitis B Birth Dose Honor Roll online.
To be included in the Hepatitis B Birth Dose Honor Roll, a birthing institution must have: (1) reported a coverage rate of 90% or greater, over a 12-month period, for administering hepatitis B vaccine before hospital discharge to all newborns, including those whose parents refuse vaccination, and (2) implemented specific written policies, procedures, and protocols to protect all newborns from hepatitis B virus infection prior to hospital discharge.
Honorees are also awarded an 8.5" x 11" color certificate suitable for framing and their acceptance is announced to IAC Express’s approximately 50,000 readers.
Please visit the Hepatitis B Birth Dose Honor Roll web page that lists these institutions and their exceptional efforts to protect infants from perinatal hepatitis B transmission.
Reminder: Nominations are now open for the National Adult and Influenza Immunization Summit excellence awards; deadline is February 13
The National Adult and Influenza Immunization Summit (NAIIS) is now soliciting nominations for the 2015 NAIIS Immunization Excellence Awards. The 2015 awards recognize individuals and organizations that made extraordinary contributions towards improving vaccination rates within their communities during 2014. The awards focus on individuals and organizations that exemplify the meaning of the “immunization neighborhood” (collaboration, coordination, and communication among immunization stakeholders dedicated to meeting the immunization needs of the patient and protecting the community from vaccine-preventable diseases). The "Adult Immunization Publication Award" has been added this year, making a total of six categories. Unless specifically indicated in the award description, the immunization activities should be broader than influenza activity. A National Winner and possibly an Honorable Mention recipient will be selected for each award category.
IAC updates "Medical Management of Vaccine Reactions in Children and Teens"
IAC recently revised Medical Management of Vaccine Reactions in Children and Teens by adding the following text on pages 2 and 3: "According to AAP's Red Book, for children age 12 years or older, the diphenhydramine maximum single dose is 100 mg."
Back to top
IAC updates "Administering Vaccines: Dose, Route, Site and Needle Size" and "Administering Vaccines to Adults: Dose, Route, Site and Needle Size"
IAC recently redesigned and made some minor edits to its healthcare professional resources Administering Vaccines: Dose, Route, Site and Needle Size and Administering Vaccines to Adults: Dose, Route, Site, and Needle Size.
IAC WEB SECTIONS
IAC updates its state immunization laws and mandates section on immunize.org; up-to-date tables and maps are available for several vaccines, including new ones for rotavirus and HPV vaccines
IAC recently updated its State Mandates on Immunization and Vaccine-preventable Diseases section on immunize.org. State data (available in both table and map formats) were revised for the following vaccines: hepatitis A (childcare/schools), hepatitis B (childcare/schools and college), influenza (childcare), meningococcal (school and college), pneumococcal (PCV), Tdap (secondary schools), and varicella (childcare/schools). Also, IAC added two new sections to state mandates: one covers human papillomavirus (HPV) vaccine mandates in secondary schools and the second is for rotavirus vaccine in childcare settings.
Note: IAC also provides links to information maintained by CDC on its State Mandates web page; these data were last updated in July 2011, according to CDC's website.
Association of Asian Pacific Community Health Organizations launches new website about people affected by hepatitis B
The Association of Asian Pacific Community Health Organizations (AAPCHO) has launched a new website to highlight stories of Asian Americans and Pacific Islanders (AAPIs) who have been affected by hepatitis B.
The "#justB" website (www.justBcampaign.org) was created to bring more attention to hepatitis B and the impact it has on the Asian American community. The website will feature a new story each month with each account representing a personal story from an individual affected by the virus, whether it be a person living with hepatitis B, an individual caring for someone with hepatitis B, or someone working within the field.
Chronic hepatitis B infection affects about two million Americans, and more than half are AAPIs. The disease is often overlooked and under-diagnosed. Within AAPI populations, many of those with hepatitis B do not want to disclose their status for fear of alienation from their communities. This campaign of stories is one step by AAPCHO and its partners to help combat the stigma faced by those with hepatitis B.
To access the website, go to www.justbcampaign.org. Contact email@example.com for more information on the project or to submit a story for consideration.
AAPCHO is a national association of 35 community health organizations dedicated to promoting advocacy, collaboration, and leadership that improves the health status and access of Asian Americans, Native Hawaiian, and other Pacific Islanders in the United States. For more information on AAPCHO, please visit www.aapcho.org.
Back to top
Influenza is spreading and serious; please keep vaccinating your patients
According to CDC, U.S. influenza activity is high across most of the country with flu illnesses, hospitalizations, and deaths elevated. Flu season will probably continue for several weeks. While the influenza vaccine may not work as well as usual against some H3N2 viruses, vaccination can still offer protection for some people, reduce hospitalizations and deaths, and will protect against other influenza viruses. Influenza vaccination is recommended for everyone six months of age and older. If you don't provide influenza vaccination in your clinic, please recommend vaccination to your patients and refer them to a clinic or pharmacy that provides vaccines or to the HealthMap Vaccine Finder to locate sites near their workplaces or homes that offer influenza vaccination services. Influenza antiviral drugs can treat influenza illness. CDC has issued guidance for clinicians on the use of antiviral treatment for the 2014–15 flu season. Early antiviral treatment works best.
Following is a list of resources related to influenza disease and vaccination for healthcare professionals and the public:
JOURNAL ARTICLES AND NEWSLETTERS
January issue of CDC's Immunization Works newsletter now available
CDC recently released the January issue of its monthly newsletter Immunization Works and posted it on the website of the National Center for Immunization and Respiratory Diseases (NCIRD). The newsletter offers the immunization community information about current topics. This information is in the public domain and can be reproduced and circulated widely.
Related Links Back to top
CDC publishes four articles about Ebola
CDC published the following three articles in the January 30 issue of MMWR. All three were previously published as MMWR Early Releases on January 23.
ASK THE EXPERTS
Question of the Week
Our patient is a 78-year-old female who received PCV13 (Prevnar13, Pfizer), then received PPSV23 (Pneumovax 23, Merck) approximately 10 weeks later. She had not received PPSV23 previously. Is the PPSV23 dose valid, or does it need to be repeated?
Answer: Even though the interval was shorter than the recommended 6–12 months, the dose of PPSV23 should be counted and does not need to be repeated. In the future, please note the ACIP recommendations for pneumococcal vaccine-naive patients age 65 and older are as follows: The dose of PPSV23 should be given 6–12 months after a dose of PCV13. If PPSV23 cannot be given during this time window, the dose of PPSV23 should be given during the next visit. The two vaccines should not be coadministered, and the minimum acceptable interval between PCV13 and PPSV23 is 8 weeks. For more information, see ACIP recommendations: Use of 13-Valent Pneumococcal Conjugate Vaccine and 23-Valent Pneumococcal Polysaccharide Vaccine Among Adults Aged ≥65 Years.
About IAC's Question of the Week
Each week, IAC Express highlights a new, topical, or important-to-reiterate Q&A. This feature is a cooperative venture between IAC and CDC. William L. Atkinson, MD, MPH, IAC's associate director for immunization education, chooses a new Q&A to feature every week from a set of Q&As prepared by experts at CDC’s National Center for Immunization and Respiratory Diseases.
We hope you enjoy this new feature and find it helpful when dealing with difficult real-life scenarios in your vaccination practice. Please encourage your healthcare professional colleagues to sign up to receive IAC Express at www.immunize.org/subscribe.
If you have a question for the CDC immunization experts, you can email them directly at firstname.lastname@example.org. There is no charge for this service.
IZ Express is supported in part by Grant No. 1NH23IP922654 from CDC’s National Center for Immunization and Respiratory Diseases. Its contents are solely the responsibility of Immunize.org and do not necessarily represent the official views of CDC.
IZ Express Disclaimer
Editor-in-ChiefKelly L. Moore, MD, MPH
Managing EditorJohn D. Grabenstein, RPh, PhD
Associate EditorSharon G. Humiston, MD, MPH
Writer/Publication CoordinatorTaryn Chapman, MS
Courtnay Londo, MA
Style and Copy EditorMarian Deegan, JD
Web Edition ManagersArkady Shakhnovich
Contributing WriterLaurel H. Wood, MPA
Technical ReviewerKayla Ohlde